The key consideration is whether your injection time allows you to monitor for side effects in a safe environment
At IFT FIRST, panelists highlighted the demands of the GLP-1 consumers and what food manufacturers must do to adapt to them
However, febuxostat was beneficial in the group of patients without proteinuria and with lower creatinine levels, suggesting that it is more effective in patients with a less renal damage
A 2021 study in The New England Journal of Medicine found that participants lost an average of 14.9% of their body weight in a 68-week period, compared to 2.4% lost without the medication
Research suggests oral GLP-1s may help consumers maintain weight loss for longer by making treatment easier, less disruptive and more sustainable day to day
Planned in-clinic or at home intravenous infusion therapy Unplanned in-clinic or at home urgent or emergent intravenous infusion therapy, combined with IV medication for the immediate relief of nausea